Participant flow16

How many started, completed or left each group, period by period.

1 to 16 of 16

Period	Milestone	Group	Participants
Overall Study	STARTED	Placebo IV Q4W	322
Overall Study	STARTED	300 mg Mirikizumab IV Q4W	959
Overall Study	STARTED	Placebo IV Q4W ME2 Cohort	41
Overall Study	STARTED	300 mg Mirikizumab IV Q4W ME2 Cohort	125
Overall Study	Received at Least One Dose of Study Drug	Placebo IV Q4W	321
Overall Study	Received at Least One Dose of Study Drug	300 mg Mirikizumab IV Q4W	958
Overall Study	Received at Least One Dose of Study Drug	Placebo IV Q4W ME2 Cohort	41
Overall Study	Received at Least One Dose of Study Drug	300 mg Mirikizumab IV Q4W ME2 Cohort	125
Overall Study	COMPLETED	Placebo IV Q4W	285
Overall Study	COMPLETED	300 mg Mirikizumab IV Q4W	920
Overall Study	COMPLETED	Placebo IV Q4W ME2 Cohort	36
Overall Study	COMPLETED	300 mg Mirikizumab IV Q4W ME2 Cohort	116
Overall Study	NOT COMPLETED	Placebo IV Q4W	37
Overall Study	NOT COMPLETED	300 mg Mirikizumab IV Q4W	39
Overall Study	NOT COMPLETED	Placebo IV Q4W ME2 Cohort	5
Overall Study	NOT COMPLETED	300 mg Mirikizumab IV Q4W ME2 Cohort	9

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03518086/flow